Incidence of Carcinoma of the Prostate in Patients with Normal Prostatic Specific Antigen Following Prostatectomy
Keywords:
Abstract
Background/Aims: Prostate cancer is fourth most common male cancer, recent data showed an increased incidence among Sudanese males and it is becoming a major medical problems and gained increased attention from Sudanese urologists. Objective: To detect patients with prostate cancer, in prostatectomy specimens, with normal preoperative PSA levels. To try to suggest a base line level of PSA above which prostatectomy should not be performed unless having a histological tissue diagnosis. Materials and methods: This is descriptive, prospective cross sectional, hospital based study, conducted at Soba University Hospital, Omdurman Military Hospital, IbnSina specialized Hospital in the period from September 2012 to August 2013All patients above 40 years of age undergoing prostectomy with normal PSA levels in the above mentioned hospitals were enrolled in this study, their surgical specimens was sent for histology. Results: The PSA level was below 4ng/ml in all cases, with a mean of 1.85ng/dl (total), and 0.36ng/dl free PSA. The histology of the prostatectomy specimens showed adenocarcinoma in 14 Pts (13.1%) and BPH in 93 pts (86.7%). Conclusion: There was a detection rate of (13.1%) among patients with PSA below ng/ml, with high grade Gleason scores. Suspicious DRE in low PSA patients enhances the cancer detection rate.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
A Jemal, T Murray, E Ward, A Samuels, R Tiwari, A Ghafoor, E Feuer, M Thun (2005) Cancer statistics, 2005. 55(1), 10.
Wakaik (2005) Descriptive epidemiology of prostate cancer in Japan and Western countries (in Japanese). 63(2), 207-212.
A Abdelkarim, Abdrabo, I Adil, Fadlalla, M Imad, Fadl-Elmul (2011) Siglen und Abkürzungen. 32, 930-932.
R Siegel Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. 61, 212-236.
M Djulbegovic, R Beyth, M Neuberger, T Stoffs, J Vieweg, B Djulbegovic, P Dahm (2011) Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. 341(sep14 1), c4543-c4543.
P Beuzeboc, M Soulié, P Richaud, L Salomon, F Staerman, M Peyromaure, P Mongiat-Artus, F Cornud, P Paparel, J Davin, V Molinié Fusion genes and 7. prostate cancer. From discovery to prognosis and therapeutic perspectives. 19(11), 819-824.
I Van Der Cruijsen-Koeter, A Vis, M Roobol, M Wildhagen, H De Koning, T Van Der Kwast, F Schroder (2005) Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam. 174(1).
(2001) American Cancer Society Guidelines for the Early Detection of Cancer. 51(2), 87-88.
A Partin, H Carter, D Chan, J Epstein, J Oesterling, R Rock (1990) PSA in staging of localized prostate cancer. Influence of tumour differentiation, tumour volume and BPH. 143, 747-752.
Carter (2000) Carter HB: A PSA threshold of 4.0 ng/mL for early detection of prostate cancer: The only rational approach for men 50 years old and older. 55, 796-799.
El Imam (2009) Prostate Specific Antigenversus Digital Rectal Examination as screening for ca prostate in Sudanese patients Sudanese. 4(2), 278-281.
A Abdelkarim, Adil Abdrabo, M Fadlallaimad, Fadl-Elmula (2011) Unknown Title. 32(11), 1131-1133.
Alexandre Pelzer, Ashutosh Tewari, Jasmin Bektic, Andreas Berger, Ferdinand Frauscher, Georg Bartsch, Wolfgang Horninger (2005) Detection rates and biologic significance of prostate cancer with PSA less than 4.0 ng/mL: Observation and clinical implications from Tyrol screening project. 66(5), 1029-1033.
E Deantoni, E Crawford, J Oesterling (1996) Age and race-specific reference ranges for prostatespecific antigen from a large community-based study. 48, 234-239.
Ted Morgan, Steven Jacobsen, William Mccarthy, Debra Jacobson, David Mcleod, Judd Moul (1996) Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men. 335(5), 304-310.
A Abdrabo, A Fadlalla, Im:Pub Fadl-Elmula, Med (2011) Age-specific reference range for serum prostatespecific antigen in Sudanese men. 32, 930-932.
William Hamilton (2005) What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. 60(12), 1059-1065.
Farmer (2001) Aio minute consultation :prostatic symptoms. 322, 146838.
R, Runtinexaertgeersb Vencastresv the diagnosis value of macroscopic haematuria for diagnosis of urological cancer in geralpractice. 003, 3135.
P Leeuwen, M Roobol, Schr ِder Fh (2010) Early detection and screening for prostate cancer.
Richard Martin, Lars Vatten, David Gunnell, Pål Romundstad (2010) Blood pressure and risk of prostate cancer: cohort Norway (CONOR). 21(3), 463-472.
Jason Krumholtz, Gustavo Carvalhal, Christian Ramos, Deborah Smith, Phataraporn Thorson, Yan Yan, Peter Humphrey, Kimberly Roehl, William Catalona (2002) Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features. 60(3), 469-473.
H Fritz, Schröder ArtoBoekenKruger:JNCI Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer. 90(23), 1817-1823.
H Jewett (1956) Significance of the palpable prostatic nodule. 10(160), 838-839.
Tineke Wolters, Monique Roobol, Pim Van Leeuwen, Roderick Van Den Bergh, Robert Hoedemaeker, Geert Van Leenders, Fritz Schröder, Theodorus Van Der Kwast (2010) A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial. 185(1), 121-125.
William Catalona, M'liss Hudson, Peter Scardino, Jerome Richie, Frederick Ahmann, Robert Flanigan, Jean Dekernion, Timothy Ratliff, Louis Kavoussi, Bruce Dalkin, W Waters, Michael Macfarlane, Paula Southwick (1994) Selection of Optimal Prostate Specific Antigen Cutoffs for Early Detection of Prostate Cancer: Receiver Operating Characteristic Curves. 152(6 Part 1), 2037-2042.
O Okotie, K Roehl, M Han, S Loeb, S Gashti, W Catalona (2007) Characteristics of prostatecancer detected by digital rectal examination only. 70(6), 1117-1120.
Thompson Iamm, Donna, Pauler, Good Phyllisj, Man Prevalence of prostate cancer among men with aprostate specific antigen level> 4ng/ml.
Published
2013-10-31
Issue
Section
License
Copyright (c) 2013 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.